Conditions: Healthy Volunteers; Asthma
Interventions: Drug: RP3128; Drug: Placebo
Sponsor: Rhizen Pharmaceuticals SA
Recruiting – verified November 2016
View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
Influence of Oral Vitamin D3 on Chronic Rhinosinusitis With Nasal Polyposis Patients and Lower Vitamin D Levels
Condition: Chronic Rhinosinusitis With Nasal Polyps
Interventions: Drug: Vitamin D; Drug: Budesonide Nasal Spray; Other: placebo
Sponsor: The First Affiliated Hospital of Shanxi Medical University
Not yet recruiting – verified January 2016
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE)
Condition: Peanut Allergy
Interventions: Biological: AR101 powder provided in capsules & sachets; Biological: Placebo powder provided in capsules & sachets
Sponsor: Aimmune Therapeutics, Inc.
Recruiting – verified December 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
An Efficacy and Safety Study of Reslizumab Subcutaneous in Patients With Oral Corticosteroid Dependent Asthma and Elevated Blood Eosinophils
Conditions: Asthma; Elevated Blood Eosinophils
Interventions: Drug: Reslizumab; Drug: Placebo
Sponsor: Teva Branded Pharmaceutical Products, R&D Inc.
Not yet recruiting – verified July 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Effect of Oral Procaterol on Postinfectious Persistent Cough
Condition: Cough
Interventions: Drug: Procaterol; Drug: Placebo
Sponsors: Mahidol University; Thai Otsuka Pharmaceutical Co.,Ltd.
Not yet recruiting – verified January 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Oral Corticosteroid Dependent Asthma (TROPOS)
Condition: Oral Corticosteroid Dependent Asthma
Interventions: Biological: Tralokinumab; Other: Placebo
Sponsor: AstraZeneca
Not yet recruiting – verified October 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Oral Immunotherapy Linked to Anaphylaxis in Teens with Asthma – HCPLive
|
Oral Immunotherapy Linked to Anaphylaxis in Teens with Asthma
HCPLive Moreover, they wrote, the fact that 3 of just 13 asthmatic adolescents in the study developed life-threatening anaphylaxis, and that all of the cases seemed to stem from their failure to follow medical directives, suggests that doctors should regard … |
View full post on asthma – Google News
Serial Lung Function Measurements in Healthy and Mild Asthmatic Adults After Oral Inhalation of Ethanolic Solutions Containing Two Concentrations of the Excipient Butylated Hydroxytoluene (BHT) Administered With the Respimat® B (RMT-B)
Condition: Asthma
Interventions: Drug: BHT 0.1%; Drug: BHT 0.5%; Drug: Placebo for RMT-B; Drug: Placebo for HFA-MDI
Sponsor: Boehringer Ingelheim
Completed – verified August 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease
Condition: Aspirin Exacerbated Respiratory Disease (AERD)
Interventions: Drug: Ifetroban, Oral Capsule; Drug: Placebo, Oral Capsule
Sponsor: Cumberland Pharmaceuticals
Active, not recruiting – verified August 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF-680 After Multiple Oral Doses” in Healthy Volunteers.
Condition: Asthma
Interventions: Drug: PBF-680; Drug: Placebo
Sponsors: Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau; Palo Biofarma, S.L
Recruiting – verified August 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days